Trial intelligence / Profile preview

Clopidogrel after asymptomatic perioperative troponin elevation in major vascular surgery

NL-OMON32253Not yet recruiting

Sponsor
Stichting Lijf en Leven
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of clopidogrel in cardiac ischemia and acute coronary syndrome (ACS) (2 arms), sponsored by Stichting Lijf en Leven. Primary endpoint: Primary composite cardiovascular endpoint. Planned start Dec 2008; status: not yet recruiting.

02

Drugs

clopidogrel
03

Conditions

cardiac ischemiaacute coronary syndrome (ACS)

Beyond the preview

Go deeper on NL-OMON32253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call